41 SEYON STREET, WALTHAM, MA
COMPLETES ACQUISITION OF BIOLIFE SOLUTIONS
Director Retirement - Karen A. Dawes Steps Down from Repligen Board
Other Events
Financial Results, Press Release
To Acquire Solutions, Expanding Its Cell Therapy Capabilities with Market Leading Biopreservation Media, Investor Presentation
2026 Annual Meeting of Stockholders - Director Nominees Elected
Reports First Quarter 2026 Financial Results and Updates Full Year 2026 Financial Guidance
Annual Report to Security Holders
Q2
Q1
FY 2024
Q3
Notice of Late Filing for Annual Report
Prospectus Filed Pursuant to Rule 425
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(3)
S-4/A
S-4
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Amended Schedule 13G - Ownership Report
Notice of Proposed Sale of Securities
Submission Upload
Correspondence